Canaccord Genuity Maintains a 'Hold' on St. Jude Medical (STJ); Quadra Approved; Doctor Letter Updates Riata
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Price: $80.82 --0%
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
3 Buy, 21 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on St. Jude Medical (NYSE: STJ) price target of $42.00.
Canaccord analyst, Jason R. Mills, said, "We continue to model ’11 and ’12 CRM sales growth of 1% and 2%, respectively, which would constrain overall top-line growth as CRM is >50% of sales. That said, STJ has a robust pipeline (e.g., CardioMems, TAVI); ergo successful, on-time launches could improve top-line growth relative to our current targets in out years. We are bullish about STJ’s ability to leverage manufacturing changes to deliver GM expansion in 2012-2014. While we expect the stock to trade in a range of $36-$42 over the next six months, noting few near-tem drivers, we would be
constructive adding to positions below this range."
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $35.69 yesterday.
Canaccord analyst, Jason R. Mills, said, "We continue to model ’11 and ’12 CRM sales growth of 1% and 2%, respectively, which would constrain overall top-line growth as CRM is >50% of sales. That said, STJ has a robust pipeline (e.g., CardioMems, TAVI); ergo successful, on-time launches could improve top-line growth relative to our current targets in out years. We are bullish about STJ’s ability to leverage manufacturing changes to deliver GM expansion in 2012-2014. While we expect the stock to trade in a range of $36-$42 over the next six months, noting few near-tem drivers, we would be
constructive adding to positions below this range."
For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.
Shares of St. Jude Medical closed at $35.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- Jefferies Downgrades IDP Education (IEL:AU) (IDPUF) to Hold
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
